ALBERT DAVID LIMITED Valuation
ALBERTDAVD · Healthcare · Current price ₹700.3
Is ALBERT DAVID LIMITED undervalued?
DocStoX estimates the fair value of ALBERT DAVID LIMITED at ₹751 per share, versus the current market price of ₹700. That puts the stock about +7.2% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹622), Relative P/E (₹1,046), Graham floor (₹682). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹622 (bear) to ₹751 (base) to ₹1,046 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
ALBERT DAVID LIMITED trades at a P/E of 23.2x and a P/B of 1.0x, with a dividend yield of 0.7%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on ALBERT DAVID LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.